Index Banner
LUX CAPITAL
The Lux Bio + Tech Index

LUXBT

Index Performance

-8.12%
LUXBT
-4.68%
IBB
+4.02%
SPY
Oct 7, 2024Oct 15, 2024Oct 23, 2024Oct 31, 2024Nov 8, 2024Nov 18, 2024Nov 26, 2024Dec 6, 2024Dec 16, 2024Dec 24, 2024Jan 7, 2025-20%-10%0%10%

Overview

Description

Developed by Lux Capital, the Lux Bio + Tech Index™ is a secular investment theme that covers companies innovating to further the molecular understanding of the "omics stack" to companies building "operating systems" for the future of drug discovery and ultimately even drug development. Over time these companies have transformed from radical, even heretical, ideas to undeniable technical, scientific, and clinical proof points. The last decade has ushered in an unparalleled understanding of the molecular basis of biology, enabled by emergent tool kits to engineer and perturb biology, ultimately increasing the velocity of discovery. Today, Moore's Law-like cost curves exist along many axes in biotech and have given rise to an era of precise, high fidelity, large scale, highly reproducible, and increasingly automated biological and chemical experimentation and discovery. The modern scientist-entrepreneur not only sits at the wetbench but also has proficiency to deconvolute high dimensional and historically unmanageable data with GPUs, the cloud, and the array of advances from machine learning and deep learning.

Full methodology
  • TickerLUXBT
  • Inception Date04/23/2021
  • WeightingEqual
  • # of holdings44
What's inside?
Sectors
  • Health Technology
    94.54%
  • Technology Services
    5.46%

Holdings

All holdings as of January 7, 2025
CSV download
Recursion Pharmaceuticals, Inc. (RXRX)6.11%$2.93B147.62%37.97%23.37
Nuvation Bio, Inc. (NUVB)3.32%$1.10BN/A-130.67%40.94
Evotec SE (EVO)3.29%$1.62B-4.87%9.89%1.76
AbCellera Biologics, Inc. (ABCL)3.23%$968.80M-1.39%-488.52%5.15
Adaptive Biotechnologies Corp. (ADPT)3.16%$1.05B22.46%58.81%4.15
Janux Therapeutics, Inc. (JANX)3.16%$3.34B-82.56%-16.17%141.56
Verve Therapeutics, Inc. (VERV)3.16%$543.54M120.24%74.45%-2.42
Schrödinger, Inc. (SDGR)2.97%$1.54B-17.10%50.24%5.55
Beam Therapeutics, Inc. (BEAM)2.84%$2.24B-17.01%61.63%3.59
BridgeBio Pharma, Inc. (BBIO)2.81%$5.45B-33.22%32.80%28.17
Erasca, Inc. (ERAS)2.66%$777.50MN/AN/AN/A
BioNTech SE (BNTX)2.54%$30.42B40.41%85.63%3.23
Vir Biotechnology, Inc. (VIR)2.51%$1.09B-9.81%-23.78%1.68
Certara, Inc. (CERT)2.49%$1.81B10.80%46.66%5.26
Roivant Sciences Ltd. (ROIV)2.49%$8.39B-87.94%94.77%28.46
Kymera Therapeutics, Inc. (KYMR)2.34%$2.65B-20.88%46.54%35.87
Revolution Medicines, Inc. (RVMD)2.30%$8.08BN/AN/A8,225.88
Prime Medicine, Inc. (PRME)2.30%$430.21MN/A-645.45%411.51
CRISPR Therapeutics AG (CRSP)2.27%$3.58BN/A-2,550.00%11.32
Ionis Pharmaceuticals, Inc. (IONS)2.27%$5.52B-7.21%95.09%6.79
SAGE Therapeutics, Inc. (SAGE)2.21%$365.82M337.08%55.54%-1.12
Alnylam Pharmaceuticals, Inc. (ALNY)2.16%$30.43B-33.26%82.85%16.86
Third Harmonic Bio, Inc. (THRD)2.15%$493.84MN/AN/AN/A
Rapport Therapeutics, Inc. (RAPP)2.10%$650.51MN/AN/AN/A
Nurix Therapeutics, Inc. (NRIX)2.09%$1.34B-31.84%67.06%25.04
CG Oncology, Inc. (CGON)2.08%$2.36BN/A51.16%2,935.36
Ultragenyx Pharmaceutical, Inc. (RARE)2.03%$4.10B42.27%78.65%10.71
Stoke Therapeutics, Inc. (STOK)1.94%$493.12M47.94%77.30%27.38
Moderna, Inc. (MRNA)1.94%$18.29B1.69%69.60%4.17
Arvinas, Inc. (ARVN)1.91%$1.34B195.95%N/A4.07
10X Genomics, Inc. (TXG)1.91%$1.88B-1.30%69.50%3.83
Nuvalent, Inc. (NUVL)1.88%$5.69BN/AN/AN/A
Denali Therapeutics, Inc. (DNLI)1.82%$3.05B-100.00%N/AN/A
Compass Pathways Plc (CMPS)1.81%$313.37MN/AN/AN/A
Dyne Therapeutics, Inc. (DYN)1.80%$2.43BN/AN/AN/A
Regeneron Pharmaceuticals, Inc. (REGN)1.77%$80.25B10.65%83.53%8.31
Relay Therapeutics, Inc. (RLAY)1.74%$773.31M-100.00%N/A20.29
Intellia Therapeutics, Inc. (NTLA)1.70%$1.27B-24.02%71.38%35.26
4D Molecular Therapeutics, Inc. (FDMT)1.57%$294.01M-99.99%-56,666.67%5.96
Fate Therapeutics, Inc. (FATE)1.34%$199.32M58.13%-49.87%15.93
Tango Therapeutics, Inc. (TNGX)1.22%$372.74M8.15%94.64%13.37
Alector, Inc. (ALEC)1.05%$193.91M68.43%85.72%0.52
Sana Biotechnology, Inc. (SANA)0.96%$368.39MN/AN/AN/A
BioAge Labs, Inc. (BIOA)0.60%$192.15MN/AN/AN/A
Market data by FactSet